TY - JOUR AU - Nakao, A. AU - Fujii, T. AU - Sugimoto, H. AU - Kanazumi, N. AU - Nomoto, S. AU - Kodera, Y. AU - Inoue, S. AU - Takeda, S. PY - 2006 DA - 2006// TI - Oncological problems in pancreatic cancer surgery JO - World J Gastroenterol VL - 12 UR - https://doi.org/10.3748/wjg.v12.i28.4466 DO - 10.3748/wjg.v12.i28.4466 ID - Nakao2006 ER - TY - JOUR AU - Sperti, C. AU - Pasquali, C. AU - Piccoli, A. AU - Pedrazzoli, S. PY - 1997 DA - 1997// TI - Recurrence after resection for ductal adenocarcinoma of the pancreas JO - World J Surg VL - 21 UR - https://doi.org/10.1007/s002689900215 DO - 10.1007/s002689900215 ID - Sperti1997 ER - TY - JOUR AU - Mollberg, N. AU - Rahbari, N. N. AU - Koch, M. AU - Hartwig, W. AU - Hoeger, Y. AU - Buchler, M. W. AU - Weitz, J. PY - 2011 DA - 2011// TI - Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis JO - Ann Surg VL - 254 UR - https://doi.org/10.1097/SLA.0b013e31823ac299 DO - 10.1097/SLA.0b013e31823ac299 ID - Mollberg2011 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Stocken, D. D. AU - Friess, H. AU - Bassi, C. AU - Dunn, J. A. AU - Hickey, H. AU - Beger, H. AU - Fernandez-Cruz, L. AU - Dervenis, C. AU - Lacaine, F. PY - 2004 DA - 2004// TI - A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa032295 DO - 10.1056/NEJMoa032295 ID - Neoptolemos2004 ER - TY - JOUR AU - Oettle, H. AU - Neuhaus, P. AU - Hochhaus, A. AU - Hartmann, J. T. AU - Gellert, K. AU - Ridwelski, K. AU - Niedergethmann, M. AU - Zulke, C. AU - Fahlke, J. AU - Arning, M. B. PY - 2013 DA - 2013// TI - Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial JO - Jama VL - 310 UR - https://doi.org/10.1001/jama.2013.279201 DO - 10.1001/jama.2013.279201 ID - Oettle2013 ER - TY - JOUR AU - Ueno, H. AU - Kosuge, T. AU - Matsuyama, Y. AU - Yamamoto, J. AU - Nakao, A. AU - Egawa, S. AU - Doi, R. AU - Monden, M. AU - Hatori, T. AU - Tanaka, M. PY - 2009 DA - 2009// TI - A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese study Group of Adjuvant Therapy for pancreatic Cancer JO - Br J Cancer VL - 101 UR - https://doi.org/10.1038/sj.bjc.6605256 DO - 10.1038/sj.bjc.6605256 ID - Ueno2009 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Moore, M. J. AU - Cox, T. F. AU - Valle, J. W. AU - Palmer, D. H. AU - McDonald, A. C. AU - Carter, R. AU - Tebbutt, N. C. AU - Dervenis, C. AU - Smith, D. PY - 2012 DA - 2012// TI - Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial JO - JAMA VL - 308 UR - https://doi.org/10.1001/jama.2012.7352 DO - 10.1001/jama.2012.7352 ID - Neoptolemos2012 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Palmer, D. H. AU - Ghaneh, P. AU - Psarelli, E. E. AU - Valle, J. W. AU - Halloran, C. M. AU - Faluyi, O. AU - O'Reilly, D. A. AU - Cunningham, D. AU - Wadsley, J. PY - 2017 DA - 2017// TI - Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial JO - Lancet VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32409-6 DO - 10.1016/S0140-6736(16)32409-6 ID - Neoptolemos2017 ER - TY - JOUR AU - Palmer, D. H. AU - Stocken, D. D. AU - Hewitt, H. AU - Markham, C. E. AU - Hassan, A. B. AU - Johnson, P. J. AU - Buckels, J. A. AU - Bramhall, S. R. PY - 2007 DA - 2007// TI - A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin JO - Ann Surg Oncol VL - 14 UR - https://doi.org/10.1245/s10434-007-9384-x DO - 10.1245/s10434-007-9384-x ID - Palmer2007 ER - TY - JOUR AU - Heinrich, S. AU - Schafer, M. AU - Weber, A. AU - Hany, T. F. AU - Bhure, U. AU - Pestalozzi, B. C. AU - Clavien, P. A. PY - 2008 DA - 2008// TI - Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial JO - Ann Surg VL - 248 UR - https://doi.org/10.1097/SLA.0b013e318190a6da DO - 10.1097/SLA.0b013e318190a6da ID - Heinrich2008 ER - TY - JOUR AU - Varadhachary, G. R. AU - Wolff, R. A. AU - Crane, C. H. AU - Sun, C. C. AU - Lee, J. E. AU - Pisters, P. W. AU - Vauthey, J. N. AU - Abdalla, E. AU - Wang, H. AU - Staerkel, G. A. PY - 2008 DA - 2008// TI - Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.8642 DO - 10.1200/JCO.2007.15.8642 ID - Varadhachary2008 ER - TY - JOUR AU - Evans, D. B. AU - Varadhachary, G. R. AU - Crane, C. H. AU - Sun, C. C. AU - Lee, J. E. AU - Pisters, P. W. AU - Vauthey, J. N. AU - Wang, H. AU - Cleary, K. R. AU - Staerkel, G. A. PY - 2008 DA - 2008// TI - Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.8634 DO - 10.1200/JCO.2007.15.8634 ID - Evans2008 ER - TY - JOUR AU - Takahashi, H. AU - Ohigashi, H. AU - Gotoh, K. AU - Marubashi, S. AU - Yamada, T. AU - Murata, M. AU - Ioka, T. AU - Uehara, H. AU - Yano, M. AU - Ishikawa, O. PY - 2013 DA - 2013// TI - Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer JO - Ann Surg VL - 258 UR - https://doi.org/10.1097/SLA.0b013e31829b3ce4 DO - 10.1097/SLA.0b013e31829b3ce4 ID - Takahashi2013 ER - TY - JOUR AU - Ohigashi, H. AU - Ishikawa, O. AU - Eguchi, H. AU - Takahashi, H. AU - Gotoh, K. AU - Yamada, T. AU - Yano, M. AU - Nakaizumi, A. AU - Uehara, H. AU - Tomita, Y. PY - 2009 DA - 2009// TI - Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer JO - Ann Surg VL - 250 UR - https://doi.org/10.1097/SLA.0b013e3181ad65cc DO - 10.1097/SLA.0b013e3181ad65cc ID - Ohigashi2009 ER - TY - STD TI - Mokdad AA, Minter RM, Zhu H, Augustine MM, Porembka MR, Wang SC, Yopp AC, Mansour JC, Choti MA, Polanco PM. Neoadjuvant therapy followed by resection versus upfront resection for Resectable pancreatic Cancer: a propensity score matched analysis. J Clin Oncol. 2016. ID - ref15 ER - TY - JOUR AU - Motoi, F. AU - Unno, M. AU - Takahashi, H. AU - Okada, T. AU - Wada, K. AU - Sho, M. AU - Nagano, H. AU - Matsumoto, I. AU - Satoi, S. AU - Murakami, Y. PY - 2014 DA - 2014// TI - Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery JO - J Hepatobiliary Pancreat Sci VL - 21 UR - https://doi.org/10.1002/jhbp.15 DO - 10.1002/jhbp.15 ID - Motoi2014 ER - TY - JOUR AU - Berger, A. C. AU - Garcia, M. AU - Hoffman, J. P. AU - Regine, W. F. AU - Abrams, R. A. AU - Safran, H. AU - Konski, A. AU - Benson, A. B. AU - MacDonald, J. AU - Willett, C. G. PY - 2008 DA - 2008// TI - Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704 JO - J Clin Oncol Off J Am Soc Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.18.6288 DO - 10.1200/JCO.2008.18.6288 ID - Berger2008 ER - TY - JOUR AU - Kinsella, T. J. AU - Seo, Y. AU - Willis, J. AU - Stellato, T. A. AU - Siegel, C. T. AU - Harpp, D. AU - Willson, J. K. AU - Gibbons, J. AU - Sanabria, J. R. AU - Hardacre, J. M. PY - 2008 DA - 2008// TI - The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer JO - Am J Clin Oncol VL - 31 UR - https://doi.org/10.1097/COC.0b013e318168f6c4 DO - 10.1097/COC.0b013e318168f6c4 ID - Kinsella2008 ER - TY - JOUR AU - Kondo, N. AU - Murakami, Y. AU - Uemura, K. AU - Hayashidani, Y. AU - Sudo, T. AU - Hashimoto, Y. AU - Nakashima, A. AU - Sakabe, R. AU - Shigemoto, N. AU - Kato, Y. PY - 2010 DA - 2010// TI - Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer JO - Ann Surg Oncol VL - 17 UR - https://doi.org/10.1245/s10434-010-1033-0 DO - 10.1245/s10434-010-1033-0 ID - Kondo2010 ER - TY - JOUR AU - Hata, S. AU - Sakamoto, Y. AU - Yamamoto, Y. AU - Nara, S. AU - Esaki, M. AU - Shimada, K. AU - Kosuge, T. PY - 2012 DA - 2012// TI - Prognostic impact of postoperative serum CA 19-9 levels in patients with resectable pancreatic cancer JO - Ann Surg Oncol VL - 19 UR - https://doi.org/10.1245/s10434-011-2020-9 DO - 10.1245/s10434-011-2020-9 ID - Hata2012 ER - TY - JOUR AU - Motoi, F. AU - Rikiyama, T. AU - Katayose, Y. AU - Egawa, S. AU - Unno, M. PY - 2011 DA - 2011// TI - Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based on RECIST guidelines JO - Ann Surg Oncol VL - 18 UR - https://doi.org/10.1245/s10434-010-1311-x DO - 10.1245/s10434-010-1311-x ID - Motoi2011 ER - TY - JOUR AU - Sugiura, T. AU - Uesaka, K. AU - Kanemoto, H. AU - Mizuno, T. AU - Sasaki, K. AU - Furukawa, H. AU - Matsunaga, K. AU - Maeda, A. PY - 2012 DA - 2012// TI - Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma JO - J Gastrointest Surg VL - 16 UR - https://doi.org/10.1007/s11605-012-1859-9 DO - 10.1007/s11605-012-1859-9 ID - Sugiura2012 ER - TY - JOUR AU - Smith, R. A. AU - Bosonnet, L. AU - Ghaneh, P. AU - Raraty, M. AU - Sutton, R. AU - Campbell, F. AU - Neoptolemos, J. P. PY - 2008 DA - 2008// TI - Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma JO - Dig Surg VL - 25 UR - https://doi.org/10.1159/000140961 DO - 10.1159/000140961 ID - Smith2008 ER - TY - JOUR AU - Berger, A. C. AU - Winter, K. AU - Hoffman, J. P. AU - Regine, W. F. AU - Abrams, R. A. AU - Safran, H. AU - Freedman, G. M. AU - Benson, A. B. AU - Macdonald, J. AU - Willett, C. G. PY - 2012 DA - 2012// TI - Five year results of US intergroup/RTOG 9704 with postoperative CA 19-9 ≤90 U/mL and comparison to the CONKO-001 trial JO - Int J Radiat Oncol Biol Phys VL - 84 UR - https://doi.org/10.1016/j.ijrobp.2012.04.035 DO - 10.1016/j.ijrobp.2012.04.035 ID - Berger2012 ER - TY - JOUR AU - Sinn, M. AU - Dälken, L. AU - Striefler, J. K. AU - Bischoff, S. AU - Schweitzer, N. AU - Pelzer, U. AU - Dörken, B. AU - Riess, H. AU - Stieler, J. M. PY - 2016 DA - 2016// TI - Second-line treatment in pancreatic Cancer patients: who profits?--results from the CONKO study group JO - Pancreas VL - 45 UR - https://doi.org/10.1097/MPA.0000000000000533 DO - 10.1097/MPA.0000000000000533 ID - Sinn2016 ER - TY - JOUR AU - Kaufmann, M. AU - Morrow, M. AU - Minckwitz, G. AU - Harris, J. R. PY - 2010 DA - 2010// TI - Biedenkopf expert panel M: Locoregional treatment of primary breast cancer: consensus recommendations from an international expert panel JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24874 DO - 10.1002/cncr.24874 ID - Kaufmann2010 ER - TY - JOUR AU - Ando, N. AU - Kato, H. AU - Igaki, H. AU - Shinoda, M. AU - Ozawa, S. AU - Shimizu, H. AU - Nakamura, T. AU - Yabusaki, H. AU - Aoyama, N. AU - Kurita, A. PY - 2012 DA - 2012// TI - A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907) JO - Ann Surg Oncol VL - 19 UR - https://doi.org/10.1245/s10434-011-2049-9 DO - 10.1245/s10434-011-2049-9 ID - Ando2012 ER - TY - JOUR AU - Takahashi, H. AU - Ohigashi, H. AU - Ishikawa, O. AU - Eguchi, H. AU - Gotoh, K. AU - Yamada, T. AU - Nakaizumi, A. AU - Uehara, H. AU - Tomita, Y. AU - Nishiyama, K. PY - 2010 DA - 2010// TI - Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival JO - Ann Surg VL - 251 UR - https://doi.org/10.1097/SLA.0b013e3181cc90a3 DO - 10.1097/SLA.0b013e3181cc90a3 ID - Takahashi2010 ER - TY - JOUR AU - Tzeng, C. W. AU - Balachandran, A. AU - Ahmad, M. AU - Lee, J. E. AU - Krishnan, S. AU - Wang, H. AU - Crane, C. H. AU - Wolff, R. A. AU - Varadhachary, G. R. AU - Pisters, P. W. PY - 2014 DA - 2014// TI - Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer JO - HPB (Oxford) VL - 16 UR - https://doi.org/10.1111/hpb.12154 DO - 10.1111/hpb.12154 ID - Tzeng2014 ER - TY - JOUR AU - Takai, S. AU - Satoi, S. AU - Toyokawa, H. AU - Yanagimoto, H. AU - Sugimoto, N. AU - Tsuji, K. AU - Araki, H. AU - Matsui, Y. AU - Imamura, A. AU - Kwon, A. H. PY - 2003 DA - 2003// TI - Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience JO - Pancreas VL - 26 UR - https://doi.org/10.1097/00006676-200304000-00007 DO - 10.1097/00006676-200304000-00007 ID - Takai2003 ER - TY - JOUR AU - Chang, D. K. AU - Johns, A. L. AU - Merrett, N. D. AU - Gill, A. J. AU - Colvin, E. K. AU - Scarlett, C. J. AU - Nguyen, N. Q. AU - Leong, R. W. AU - Cosman, P. H. AU - Kelly, M. I. PY - 2009 DA - 2009// TI - Margin clearance and outcome in resected pancreatic cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.5104 DO - 10.1200/JCO.2008.20.5104 ID - Chang2009 ER - TY - STD TI - Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F: The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg1337–1344. ID - ref32 ER - TY - JOUR AU - Sa Cunha, A. AU - Rault, A. AU - Laurent, C. AU - Adhoute, X. AU - Vendrely, V. AU - Bellannee, G. AU - Brunet, R. AU - Collet, D. AU - Masson, B. PY - 2005 DA - 2005// TI - Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas JO - J Am Coll Surg VL - 201 UR - https://doi.org/10.1016/j.jamcollsurg.2005.04.008 DO - 10.1016/j.jamcollsurg.2005.04.008 ID - Sa Cunha2005 ER - TY - JOUR AU - Satoi, S. AU - Yamaue, H. AU - Kato, K. AU - Takahashi, S. AU - Hirono, S. AU - Takeda, S. AU - Eguchi, H. AU - Sho, M. AU - Wada, K. AU - Shinchi, H. PY - 2013 DA - 2013// TI - Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery JO - J Hepatobiliary Pancreat Sci VL - 20 UR - https://doi.org/10.1007/s00534-013-0616-0 DO - 10.1007/s00534-013-0616-0 ID - Satoi2013 ER - TY - JOUR AU - Kato, K. AU - Kondo, S. AU - Hirano, S. AU - Tanaka, E. AU - Shichinohe, T. AU - Tsuchikawa, T. AU - Matsumoto, J. PY - 2011 DA - 2011// TI - Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy JO - J Hepatobiliary Pancreat Sci VL - 18 UR - https://doi.org/10.1007/s00534-011-0391-8 DO - 10.1007/s00534-011-0391-8 ID - Kato2011 ER -